文献速递哮喘呼吸道感染

金黄色葡萄球菌及其诱导IgE的肠毒素在哮喘中的作用:当前认识

Staphylococcus aureus and its IgE-inducing enterotoxins in asthma: current knowledge.
PubMed 文献 · Eur Respir J · 2020-04-03

本文综述金黄色葡萄球菌及其蛋白(包括肠毒素、Spls、SpA)在哮喘中的免疫调控作用。在晚发型重症哮喘患者血清中常可检出针对葡萄球菌肠毒素的特异性IgE,且该指标可预测未来十年内重症哮喘伴急性发作的发展。金黄色葡萄球菌通过释放IL-33、激活ILC2和Th2细胞、诱导B细胞活化与IgE形成、吸引嗜酸性粒细胞等机制参与重症气道炎症。

要点

  • 晚发型重症哮喘患者血清中可检出葡萄球菌肠毒素特异性IgE,与重症哮喘相关。
  • 葡萄球菌肠毒素特异性IgE可预测未来十年内重症哮喘伴急性发作的发展。
  • 金黄色葡萄球菌通过IL-33/ILC2/Th2轴、肥大细胞脱颗粒和嗜酸性粒细胞募集调控气道免疫。

核心结论

  • 金黄色葡萄球菌在重症气道炎症的编排和当前及未来疾病严重程度中占有重要地位。

研究设计与样本

  • 本文为综述,讨论金黄色葡萄球菌及其蛋白在哮喘中作用领域的当前认识,并展望未来研究方向。

主要发现

  • 晚发型哮喘中IgE表达多呈多克隆模式,特异性IgE低或低于检测水平,但总IgE升高。
  • 在晚发型重症哮喘患者血清中常可检出针对葡萄球菌肠毒素的特异性IgE,且与哮喘相关。
  • 重症哮喘的定义包括住院、口服激素使用和肺功能下降。
  • 葡萄球菌肠毒素特异性IgE可预测未来十年内重症哮喘伴急性发作的发展。
  • 金黄色葡萄球菌通过超抗原、丝氨酸蛋白酶样蛋白(Spls)和蛋白A(SpA)等蛋白在多个层面调控气道黏膜免疫。

关键数值与推荐

  • 重症哮喘定义包括住院、口服激素使用和肺功能下降。
  • 金黄色葡萄球菌调控黏膜免疫的关键环节包括:呼吸道上皮释放IL-33、经ST2受体激活固有淋巴样细胞(ILCs)、ILCs和Th2细胞释放2型细胞因子、肥大细胞脱颗粒、局部B细胞大量活化与IgE形成、嗜酸性粒细胞吸引及胞外诱捕网释放。
  • 嗜酸性粒细胞释放的胞外诱捕网加重上皮损伤,并通过形成Charcot-Leyden晶体参与疾病持续。

临床怎么用

  • 对晚发型重症哮喘患者可关注血清葡萄球菌肠毒素特异性IgE,作为重症哮喘及未来急性发作风险的生物标志物。
  • 金黄色葡萄球菌及其蛋白参与重症哮喘炎症的多个环节,可能为未来干预提供靶点。

局限性

  • 本文为综述,未报告原始研究的设计、样本量或统计值。
  • 金黄色葡萄球菌及其蛋白影响哮喘的完整机制尚需未来研究进一步阐明。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

While immunoglobulin (Ig) E is a prominent biomarker for early-onset, its levels are often elevated in non-allergic late-onset asthma. However, the pattern of IgE expression in the latter is mostly polyclonal, with specific IgEs low or below detection level albeit with an increased total IgE. In late-onset severe asthma patients, specific IgE to Staphylococcal enterotoxins (se-IgE) can frequently be detected in serum, and has been associated with asthma, with severe asthma defined by hospitalisations, oral steroid use and decrease in lung function. Recently, se-IgE was demonstrated to even predict the development into severe asthma with exacerbations over the next decade. Staphylococcus aureus manipulates the airway mucosal immunology at various levels via its proteins, including superantigens, serine-protease-like proteins (Spls), or protein A (SpA) and possibly others. Release of IL-33 from respiratory epithelium and activation of innate lymphoid cells (ILCs) via its receptor ST2, type 2 cytokine release from those ILCs and T helper (Th) 2 cells, mast cell degranulation, massive local B-cell activation and IgE formation, and finally eosinophil attraction with consequent release of extracellular traps, adding to the epithelial damage and contributing to disease persistence via formation of Charcot-Leyden crystals are the most prominent hallmarks of the manipulation of the mucosal immunity by S. aureus In summary, S. aureus claims a prominent role in the orchestration of severe airway inflammation and in current and future disease severity. In this review, we discuss current knowledge in this field and outline the needs for future research to fully understand the impact of S. aureus and its proteins on asthma.

来源:Eur Respir J,查看原文。版权归原作者所有。

引用

  1. Bachert C, Humbert M, Hanania NA, et al. Staphylococcus aureus and its IgE-inducing enterotoxins in asthma: current knowledge. Eur Respir J. 2020. PMID: 31980492. doi:10.1183/13993003.01592-2019

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。